Leukapheresis products market overview and analysis by type, application, end user-forecast till 2032. Leukapheresis is a laboratory procedure in which white blood cells (WBCs) are separated from a sample of blood. Leukapheresis is majorly carried out for chronic lymphocytic leukemia. It is projected to grow at a CAGR of 7.8% over the forecast period.
Over the projection period, it is projected that factors including rising blood donation rates, an increase in the incidence of leukaemia, and demand for leukapheresis products in clinical research will fuel market expansion. Estimates from the National Institutes of Health (NIH) show that between 2006 and 2015, there were an average of 0.3% more new cases of leukaemia per year. The possibility of 60,300 more cases was also mentioned. Despite the drivers, the market expansion may be hampered over the evaluation period by the high cost of therapeutic leukapheresis, a lack of qualified experts, and strict donor recruiting requirements.
Several businesses are now active in the worldwide leukapheresis products market. To improve their market position, the major players in the industry are launching new products, expanding regionally, and collaborating strategically. Through this partnership, Terumo BCT will increase its distribution of StafaCT software to healthcare organisations and serve as a distributor for Stafa Cellular Therapy.
Key Players:
Some of the prominent players in the global leukapheresis products market are Haemonetics, Terumo BCT, Asahi Kasei Medical, STEMCELL Technologies, Macopharma, HemaCare Corporation, Caltag Medsystem, ALLCells, LLC, ZENBIO, Fresenius Kabi, PPA Research Group, and StemExpress
Segmentation:
The global leukapheresis products market size has been segmented into type, application, and end user.
On the basis of type, the market has been segmented into leukapheresis devices and leukapheresis disposables. The leukapheresis devices segment has been segmented into apheresis devices, leukapheresis column cell separators, and leukoreduction filters.
The market, by application, has been segmented into research applications and therapeutic applications.
On the basis of end user, the market has been segmented into blood component providers and blood centers, hospitals and transfusion centers, and others.
Regional Analysis:
Geographically, the Americas is anticipated to dominate the global leukapheresis products market owing to the rising number of blood donations, and growing incidence and prevalence of leukemia. Europe is anticipated to hold the second largest position in the global leukapheresis products market. The market growth in this region is mainly due to the rising prevalence of leukemia and presence of well-developed healthcare sector in the region. Asia-Pacific region is expected to be fastest growing region due to the increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the increasing presence of major pharma and biotech companies. The Middle East Africa has the least share of the global leukapheresis products market owing the poor healthcare infrastructure especially in the Africa region.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
